UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues	$ 1,490,100	$ 1,565,959	$ 2,790,200	$ 2,866,005
Operating expenses
General and administrative	363,230	265,165	637,775	506,402
Rent expense	274,130	105,933	539,263	220,497
Management fees		215,503		243,003
Professional fees	301,132	177,910	455,682	289,114
Salaries and wages	717,032	629,707	1,440,773	1,221,743
Depreciation and amortization	112,086	139,595	223,292	278,074
Total operating expenses	1,767,610	1,533,813	3,296,785	2,758,833
Operating loss (income)	(277,510)	32,146	(506,585)	107,172
Other Income (expense)
Other income		339		339
Penalty on convertible debt		(34,688)		(34,688)
Extension fee – property purchase		(130,000)		(130,000)
Interest income	523		1,098
Interest expense	(106,914)	(143,981)	(200,100)	(301,077)
Amortization of debt discount	(75,240)	(87,526)	(138,402)	(164,447)
Foreign exchange movements	(6,134)	(87,791)	4,511	(90,746)
Net loss before income taxes	(465,275)	(451,501)	(839,478)	(613,447)
Income taxes		219,346		205,575
Net loss	(465,275)	(232,155)	(839,478)	(407,872)
Net loss (income) attributable to non-controlling interest	101,842	(93,880)	101,842	(96,848)
Net loss allocable to Ethema Health Corporation Stockholders	(363,433)	(326,035)	(737,636)	(504,720)
Preferred stock dividend		(5,984)		(11,901)
Preferred stock dividend – non controlling interest		(17,822)		(35,324)
Net loss available to common shareholders of Ethema Health Corporation	(363,433)	(349,841)	(737,636)	(551,945)
Accumulated other comprehensive income (loss)
Foreign currency translation adjustment		6,569		5,065
Total comprehensive loss	$ (363,433)	$ (343,272)	$ (737,636)	$ (546,880)
Loss per share - Basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Loss per share - Diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding basic	3,729,053,805	3,729,053,805	3,729,053,805	3,729,053,085
Weighted average common shares outstanding diluted	3,729,053,805	3,729,053,805	3,729,053,805	3,729,053,085